| Literature DB >> 34503685 |
Ambarish Pandey1, Sanjiv J Shah2, Javed Butler3, Dean L Kellogg4, Gregory D Lewis5, Daniel E Forman6, Robert J Mentz7, Barry A Borlaug8, Marc A Simon6, Julio A Chirinos9, Roger A Fielding10, Elena Volpi11, Anthony J A Molina12, Mark J Haykowsky13, Flora Sam14, Bret H Goodpaster15, Alain G Bertoni16, Jamie N Justice16, James P White17, Jingzhone Ding16, Scott L Hummel18, Nathan K LeBrasseur8, George E Taffet19, Iraklis I Pipinos20, Dalane Kitzman21.
Abstract
Exercise intolerance (EI) is the primary manifestation of chronic heart failure with preserved ejection fraction (HFpEF), the most common form of heart failure among older individuals. The recent recognition that HFpEF is likely a systemic, multiorgan disorder that shares characteristics with other common, difficult-to-treat, aging-related disorders suggests that novel insights may be gained from combining knowledge and concepts from aging and cardiovascular disease disciplines. This state-of-the-art review is based on the outcomes of a National Institute of Aging-sponsored working group meeting on aging and EI in HFpEF. We discuss aging-related and extracardiac contributors to EI in HFpEF and provide the rationale for a transdisciplinary, "gero-centric" approach to advance our understanding of EI in HFpEF and identify promising new therapeutic targets. We also provide a framework for prioritizing future research, including developing a uniform, comprehensive approach to phenotypic characterization of HFpEF, elucidating key geroscience targets for treatment, and conducting proof-of-concept trials to modify these targets.Entities:
Keywords: aging; exercise intolerance; heart failure with preserved ejection fraction; senescence; skeletal muscle
Mesh:
Year: 2021 PMID: 34503685 PMCID: PMC8525886 DOI: 10.1016/j.jacc.2021.07.014
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 27.203